Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost dose-ranging for eyelash hypotrichosis
NCT01064882Phase 2Completed
- Sponsor
- Allergan
- Start
- Mar 2010
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bimatoprost in eyelash hypotrichosis, sponsored by Allergan. Started Mar 2010; status: completed.
02
Drugs
bimatoprost
03
Conditions
eyelash hypotrichosis
Beyond the preview
Go deeper on NCT01064882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064882.